Recent Use of Antibiotics Doubles Your Chances of Being Resistant
Posted on: Tuesday, 19 July 2005, 14:49 CDT
A new study has shown that a prescription of antibiotics taken within the previous two months doubles the chances of patients carrying antibiotic resistant bacteria. The same effect was not seen in patients who had had antibiotics prescribed within the previous 12 months.
While information from large data sets suggest that high levels of antibiotic use is related to antibiotic resistance, this is the first time that the risk to the individual has been assessed. The study looked at whether GP prescribing of antibiotics increases an individual’s risk of developing antibiotic resistance.
GPs are responsible for 80% of all antibiotics prescribed in the United Kingdom, despite evidence of limited or marginal effectiveness for the most common reason to prescribe, namely respiratory tract infections such as sore throats, coughs and earache. This could be partly due to patients’ expectations of being treated with antibiotics.
Dr Alastair Hay, from Bristol University who is also a GP in the city said: “Although GPs are aware of the problem in the population as a whole, when deciding whether or not to prescribe antibiotics for an individual they may consider the risk as being minimal.”
Resistance was tested in organisms from urine samples submitted by 3,000 adults without urinary symptoms registered with 12 GP practices in the Bristol and Gloucester areas. Hay and colleagues from across the South West found information on bacterial resistance and antibiotic consumption in 618 patients from their primary care medical records regarding the number, type, strength and duration of antibiotic courses prescribed in the 12 months prior to urine sample submission.
The urinary E. coli bacteria found in low concentrations were defined as resistant if they demonstrated resistance to the antibiotic amoxicillin or the antibiotic trimethoprim, or both antibiotics.
The results showed that antibiotics prescribed in the 12 months prior to obtaining the urine sample did not influence the resistance of organisms – presumably because the time period in question is too long. However, the more recent use of antibiotics – within 2 months – led to a near doubling of the likelihood of resistance.
The team also found that over a 12 month period prior to sampling, each additional tablet of trimethoprim (200mg) prescribed increased the chances of developing resistance. In addition, the degree of resistance to amoxicillin was greater in patients prescribed any penicillin antibiotic in the 12 months prior to urine sampling.
Funded by the British Society for Antimicrobial Chemotherapy, the results of this work are published in the Journal of Antimicrobial Chemotherapy this month [July 2005]
This is the first time the risk to individuals being prescribed antibiotics by their GP has been measured. This research should be repeated but in the meantime both patients and GPs should take account of this information when deciding whether to prescribe and consume antibiotics.
On the World Wide Web:
Related Articles
- New Data From Arena Pharmaceuticals' Pivotal BLOSSOM Trial of Lorcaserin Demonstrate Improvements in Patients' Body Composition, Cardiovascular Risk Factors and Quality of Life
- New Data Presented From WELCOME Trial Show Positive Impact of CIMZIA(R) (certolizumab pegol) on Hospitalizations and Surgeries in Patients With Prior Infliximab Failure
- Atrial Fibrillation Found to Be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke
- Methamphetamine Use Associated With Pulmonary Arterial Hypertension in Patients With Previously Unknown Risk Factors
- American Heart Association Scientific Statement: AHA Statement Recommends Doctors Change Approach to Prescribing Pain Relievers for Patients With or at Risk for Heart Disease
- NuVim(R) Records 10 Consecutive Months of Sales Increases Versus Same Month Prior Year, Improves Products to Increase Consumer Health and Forecasts Going Cash Positive in 3rd Quarter
- Statement By ZixCorp Supporting the Launch of The National E-Prescribing Patient Safety Initiative
- Statement By InstantDx/OnCallData Chairman and CEO Dr. Allan M. Weinstein Supporting the Launch of The National E-Prescribing Patient Safety Initiative
- The Market Share of Low-Cost Carriers in Europe Reached 16.3% in May 2006 - a Full 2.4% Higher Than at the Same Point 12 Months Prior
- FDA Approves Expansion of Angiomax(R) (Bivalirudin) Label to Include Patients With or at Risk of HIT/HITTS Undergoing PCI; HIT/HITTS Places Patients at Higher Risk of Life-Threatening Complications
User Comments (0)

RSS Feeds